|
|
Article: PEG-Intron and Rebetol.(Brief Article)
- Article from:
- Family Practice News
- Article date:
- September 15, 2001
- Author:
CopyrightCOPYRIGHT 2001 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(peginterferon alfa-2b and ribavirin, Schering-Plough Corp.)
A long-acting formulation of Intron-A (interferon alfa-2b) in combination with the antiviral Rebetol, for people aged 18 and over who have chronic hepatitis C infections with compensated liver disease, and who have not been treated previously with alfa-interferon. This combination of PEG-Intron and Rebetol is now considered the standard of care for patients who have chronic hepatitis C infection.
Intron-A and other interferons were previously approved for treating hepatitis C. The combination of Intron-A and Rebetol was previously approved because of the improved patient response, compared with ...